Solving the conundrum of insoluble protein aggregates

The Lancet Neurology

Volumn 16, Issue 4, 2017, Pages 258-259

  George, Sonia ^a   Brundin, Patrik ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; PROTEIN AGGREGATE; TAU PROTEIN; PROTEIN;

AGING; ALZHEIMER DISEASE; ASTROCYTE; DEGENERATIVE DISEASE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MICROGLIA; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN MISFOLDING;

PROTEIN AGGREGATES; PROTEINS;

EID: 85013652187     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(17)30045-5     Document Type: Note

References (11)

1. 1 Goedert, M, Clavaguera, F, Tolnay, M, The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33 (2010), 317–325.
2. 2 Stopschinski, BE, Diamond, MI, The prion model for progression and diversity of neurodegenerative diseases. Lancet Neurology, 2017 published online Feb 23. http://dx.doi.org/10.1016/S1474-4422(17)30037-6.
3. 3 Valastyan, JS, Lindquist, S, Mechanisms of protein-folding diseases at a glance. Dis Model Mech 7 (2014), 9–14.
4. 4 Kalinderi, K, Bostantjopoulou, S, Fidani, L, The genetic background of Parkinson's disease: current progress and future prospects. Acta Neurol Scand 134 (2016), 314–326.
5. 5 Jin, S-G, Zhang, Z-M, Dunwell, TL, et al. Tet3 reads 5-carboxylcytosine through Its CXXC domain and is a potential guardian against neurodegeneration. Cell Rep 14 (2016), 493–505.
6. 6 Ciechanover, A, Kwon, YT, Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med, 47, 2015, e147.
7. 7 Bliederhaeuser, C, Grozdanov, V, Speidel, A, et al. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes. Acta Neuropathol 131 (2016), 379–391.
8. 8 Soreq, L, Rose, J, Soreq, E, et al. Major shifts in glial regional identity are a transcriptional hallmark of human brain aging. Cell Rep 18 (2017), 557–570.
9. 9 Chin-Chan, M, Navarro-Yepes, J, Quintanilla-Vega, B, Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci, 9, 2015, 914.
10. 10 Sampson, TR, Debelius, JW, Thron, T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167 (2016), 1469–1480.
11. 11 Kaufman, SK, Sanders, DW, Thomas, TL, et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92 (2016), 796–812.